China Pharma Holdings (CPHI) Operating Expenses (2010 - 2026)

China Pharma Holdings' Operating Expenses history runs 17 years deep, the most recent figure standing at $1.4 million for Q1 2026.

• Quarterly Operating Expenses rose 125.32% year-over-year to $1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.9 million (up 49.53% YoY) and the FY2025 annual result came in at $3.1 million, up 19.36% from the prior year.
• Operating Expenses was $1.4 million for Q1 2026 at China Pharma Holdings, up from $1.4 million in the prior quarter.
• Across five years, Operating Expenses topped out at $1.4 million in Q1 2026 and bottomed at $309647.0 in Q2 2023.
• A 5-year average of $743464.3 and a median of $575403.0 in 2023 frame the typical range for Operating Expenses.
• Annual changes were most pronounced in 2023 — Operating Expenses tumbled 43.72% — and 2026, when it soared 125.32%.
• China Pharma Holdings' Operating Expenses stood at $1.2 million in 2022, then declined by 8.78% to $1.1 million in 2023, then decreased by 6.32% to $1.0 million in 2024, then jumped by 30.47% to $1.4 million in 2025, then increased by 3.83% to $1.4 million in 2026.
• Business Quant data shows CPHI's Operating Expenses at $1.4 million in Q1 2026, $1.4 million in Q4 2025, and $568491.0 in Q3 2025.